```html

Zhenghe disease (historical term for Typhoid fever) – A Comprehensive Medical Guide

Overview

Zhenghe disease is an antiquated name that appeared in Chinese medical texts during the Ming and Qing dynasties to describe a severe, prolonged fever with gastrointestinal symptoms. Modern scholars now identify Zhenghe disease as typhoid fever, an infection caused by the bacterium Salmonella enterica serovar Typhi (S. Typhi).

• Who it affects: Anyone can become infected, but the disease is most common in children aged 5‑15 and adults living in areas with poor sanitation.
• Global prevalence: The World Health Organization (WHO) estimates 10‑20 million new cases of typhoid each year, resulting in 100,000–150,000 deaths worldwide, largely in South Asia and sub‑Saharan Africa.<sup>WHO 2023</sup>
• Historical context: In imperial China, Zhenghe disease was recorded during epidemics in the 16th–18th centuries, often linked to contaminated water supplies during floods.

Symptoms

Symptoms typically appear 6–30 days after exposure (the incubation period) and evolve over three phases. Not every patient experiences all signs.

Early (Week 1)

• Stepwise fever: Gradual rise to 38‑40 °C (100‑104 °F), often highest in the afternoon.
• Headache: Diffuse, sometimes described as “brain pressure.”
• General malaise: Weakness, fatigue, and loss of appetite.
• Abdominal discomfort: Cramping, mild nausea.

Middle (Week 2)

• Rose‑colored rash (rose spots): Small (2‑4 mm), painless macules on the trunk and chest; seen in 5‑10 % of patients.
• Diarrhea or constipation: Either pattern may dominate; stool may contain blood or mucus.
• Enlarged spleen and liver: Palpable on physical exam in up to 30 % of cases.

Late (Week 3‑4)

• Persistent high fever: May exceed 41 °C (105.8 °F) without antipyretics.
• Severe abdominal pain: Possible intestinal ulceration.
• Neurologic signs: Confusion, delirium, or mild encephalopathy in 10‑15 %.
• Bleeding: Gastrointestinal bleeding or hematemesis in complicated cases.

Because these features overlap with other febrile illnesses (e.g., malaria, dengue, COVID‑19), laboratory confirmation is essential.

Causes and Risk Factors

Primary cause

Typhoid fever is caused by ingestion of food or water contaminated with the feces of an infected person carrying S. Typhi. The bacteria survive in the gut, penetrate the intestinal mucosa, and spread via the bloodstream to multiple organs.

Key risk factors

• Unsafe water: Consumption of untreated surface water, especially during floods or after natural disasters.
• Contaminated food: Street‑vended salads, raw vegetables, and unpasteurized dairy products prepared by infected handlers.
• Poor sanitation: Lack of latrines, open defecation, and inadequate sewage disposal.
• Travel: Visiting endemic regions without appropriate vaccination or precautions.
• Age: Children 5‑15 years old have higher attack rates.
• Immunocompromise: HIV infection, malnutrition, or chronic liver disease increases susceptibility.
• Carrier state: Approximately 2‑5 % of infected individuals become chronic carriers (most commonly the gallbladder), shedding bacteria for years.

Diagnosis

Timely diagnosis reduces morbidity and mortality. Clinicians combine clinical suspicion with laboratory testing.

Laboratory tests

• Blood culture: Gold‑standard; positive in 40‑80 % of cases if taken before antibiotics. Usually performed 2–3 days after fever onset.
• Bone‑marrow culture: Highest sensitivity (up to 95 %) but invasive; reserved for severe or ambiguous cases.
• Stool and urine cultures: Helpful after the first week; useful for identifying chronic carriers.
• Serologic tests (Widal test): Detects anti‑O and anti‑H antibodies. Widely used in low‑resource settings but limited by low specificity; results must be interpreted with local baseline titers.
• Rapid molecular assays: PCR‑based kits (e.g., Xpert Typhoid) provide results in <12 h with >90 % sensitivity, increasingly available in reference labs.

Imaging (supportive)

Ultrasound or CT may reveal hepatosplenomegaly or intestinal ulcerations in complicated disease but are not diagnostic.

Treatment Options

Effective therapy combines antibiotics, supportive care, and, when needed, surgical intervention.

Antibiotic regimens (first‑line)

• Ceftriaxone: 2 g IV/IM once daily for 10‑14 days. Preferred in areas with high fluoroquinolone resistance.
• Azithromycin: 1 g orally on day 1, then 500 mg daily for 6 days; useful for uncomplicated cases and in pregnancy.
• Fluoroquinolones (e.g., ciprofloxacin): 500 mg PO twice daily for 7‑10 days; recommended only where susceptibility is confirmed (<5 % resistance).

Alternative/second‑line agents

• Chloramphenicol (50 mg/kg/day divided q6h) – limited by bone‑marrow toxicity.
• Trimethoprim‑sulfamethoxazole (TMP‑SMX) – useful in children when susceptibility is proven.

Supportive care

• Hydration: Oral rehydration solutions or IV fluids to correct dehydration from fever, diarrhea, or vomiting.
• Antipyretics: Acetaminophen (paracetamol) for fever; avoid NSAIDs if gastrointestinal bleeding is suspected.
• Nutritional support: Light, easily digestible meals; protein‑rich foods to aid recovery.

Surgical considerations

In rare cases of intestinal perforation or massive hemorrhage, emergency laparotomy is required. Post‑operative antibiotics are continued for 2‑4 weeks.

Living with Zhenghe disease (a historical term for Typhoid fever)

Even after acute infection resolves, patients may need guidance to avoid relapse and to protect close contacts.

Recovery phase (first 2‑3 weeks)

• Rest adequately; avoid strenuous activity until fever has been absent for at least 48 hours.
• Continue full antibiotic course even if you feel better.
• Maintain strict hand‑washing with soap and water after using the toilet.
• Consume safe water (boiled, filtered, or bottled) and well‑cooked foods.

Long‑term considerations

• Carrier testing: If you had typhoid >1 month ago, ask your physician for stool cultures to rule out chronic carriage.
• Gallbladder health: Chronic carriers often have gallstones; ultrasound screening may be advised.
• Vaccination for future exposure: Typhoid conjugate vaccine (TCV) provides >80 % protection for up to 5 years.

Psychosocial tips

• Inform school or workplace about the infection; most institutions require a doctor’s note confirming you’re no longer infectious (typically after 24 h of appropriate antibiotics and fever‑free).
• Seek counseling if prolonged fatigue or “brain fog” affects daily life; post‑typhoid syndrome can last weeks.

Prevention

Prevention hinges on breaking the fecal‑oral transmission cycle.

Vaccination

• Typhoid conjugate vaccine (TCV): Single dose for ages 6 months‑45 years; booster recommended every 5 years for high‑risk individuals.
• Vi polysaccharide vaccine: Two‑dose series for adults ≥2 years; shorter duration of protection (≈2 years).

Safe water & food practices

• Boil water for ≥1 minute or treat with chlorine tablets (1 mg/L) before drinking.
• Eat only fully cooked hot foods; avoid raw salads, unpeeled fruits, and street‑vended items unless you’re certain of hygiene.
• Use safe sanitation: latrines with sealed waste, hand‑washing stations with soap.

Travel precautions

• Get vaccinated at least 2 weeks before departure to endemic areas.
• Carry oral rehydration salts and a small bottle of bottled water.
• Avoid ice, unpasteurized dairy, and foods prepared by ill persons.

Community measures

• Improved sewage treatment and access to clean water (WHO/UNICEF Joint Monitoring Programme).
• Active surveillance and rapid outbreak response by public‑health authorities.
• Identification and treatment of chronic carriers to eliminate reservoirs.

Complications

When untreated or inadequately treated, typhoid fever can be life‑threatening.

• Intestinal perforation: Occurs in 1‑5 % of untreated patients; presents with sudden abdominal pain and peritonitis.
• Severe hemorrhage: From ulcerated intestinal lesions; may lead to hypovolemic shock.
• Typhoid encephalopathy: Confusion, seizures, or coma; associated with high mortality.
• Hepatosplenomegaly and cholestatic hepatitis: Jaundice and liver dysfunction.
• Endocarditis or osteomyelitis: Rare, usually in immunocompromised hosts.
• Chronic carrier state: Persistent shedding of bacteria; risk of secondary outbreaks.

When to Seek Emergency Care

---

For more information, visit reputable sources such as the U.S. Centers for Disease Control and Prevention (CDC), Mayo Clinic, and the World Health Organization (WHO).

```